Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Upadacitinib effectively treats psoriasis and lichen planus together.

Tofacitinib taken by mouth helps treat hair loss in children.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib might be used to treat hair loss.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

Ritlecitinib works well and is safe for treating alopecia areata.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Tofacitinib treatment is used for teenagers with alopecia areata.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Ritlecitinib effectively treats alopecia areata with manageable side effects.